Balliu, M., Boldrini, V., Maccari, C., Colazzo, D., Sestini, I., Conza, G. D., Lahn, M., Guglielmelli, P., Vannucchi, A. (2025). The selective PI3Kδ inhibitor roginolisib synergizes with ruxolitinib against progenitor cells from naïve and JAK inhibitor-refractory/resistant patients with myelofibrosis. Blood. https://doi.org/10.1182/blood-2025-5529